Calls Now Open
2027 Scholar-Innovator and ADDF-Harrington
May 12, 2026
May 12, 2026, CLEVELAND, Ohio - Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2026 class of Harrington Scholar-Innovators. The scholar awards will support breakthrough new treatments for common and rare diseases, including cardiovascular, inflammatory, hematologic, and oncologic...
Continue Reading
May 06, 2026
Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center Continue Reading
April 21, 2026
Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading
March 24, 2026
2026 Harrington Prize for Innovation in Medicine recognizes pioneering work in prostate cancer diagnosis and treatment Continue Reading
March 10, 2026
The annual Cozzarelli Prize acknowledges papers that reflect scientific excellence and originality. Continue Reading
January 15, 2026
Prestigious Scholar Award Accelerates Novel Therapies for Patients with Rare Diseases Continue Reading
December 23, 2025
New Study from University Hospitals and Case Western Reserve University published in Science Signaling Continue Reading
December 22, 2025
For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease prevention or slowing, rather than recovery. Despite billions of dollars spent on decades of research, there has never been a clinical trial of a drug for AD with an outcome goal of reversing disease and... Continue Reading
November 20, 2025
Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat rare and ultra-rare diseases Continue Reading
November 13, 2025
Positive results at AHA Scientific Sessions, published in NEJM Evidence Continue Reading
October 15, 2025
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines Continue Reading